The push to make the lifesaving opioid overdose antidote easier to buy took five years and multiple court battles, fueling worries about access and supply.
opioid epidemic
Our View: Settlement should be used to repair damage from opioid addiction
Companies that brought about the crisis will pay tens of millions of dollars to Maine. We must use it the right way.
Hundreds gather in Portland to support people in recovery
Portland Recovery Community Center held its 10th annual Rally 4 Recovery to give hope to people seeking to overcome addiction.
As opioid settlement funds reach Maine, debate arises over how to use them
A nationwide coalition urges support for community-based organizations while some municipalities already plan to expand existing programs.
Maine addiction recovery advocates notch legislative wins, eye future battles
Advocates secured additional funding for treatment beds and expanded access to naloxone last session. Another bill to create safe consumption sites failed, but the state will study the idea in the coming year.
OxyContin maker’s bankruptcy, which shields Sackler family, can move ahead
Under a bankruptcy agreement, members of the wealthy Sackler family who own Purdue Pharma will be protected from civil lawsuits over the opioid crisis.
Mills administration to distribute test strips to fight latest overdose threat
A sedative named xylazine is being combined with fentanyl, and the combination is driving up the number of fatal overdoses in Maine and the United States.
Lewiston council denies permit for Church of Safe Injection barbecue
A statement from the Church of Safe Injection said it’s ‘evident’ from listening to the councilors who voted to deny the permit that ‘there is considerable confusion about our organization and what we do.’
Animal sedative adds new suffering to opioid drug crisis, but is it driving up deaths?
Xylazine can cause severe skin wounds, but whether it is leading to more deaths is not yet clear.
Maine will receive at least $235 million in settlements from companies accused of fueling the opioid crisis
A Maine Monitor analysis looks at who stands to benefit from this money and why it matters.